| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC | 950,600 | 74,993,000 | 34.47% | ||
| 2 | CIT GROUP INC | 1,070,857 | 52,151,000 | 23.97% | ||
| 3 | ATRICURE INC | 1,855,000 | 44,984,000 | 20.67% | ||
| 4 | CORINDUS VASCULAR ROBOTICS INCORPORATED | 11,336,154 | 21,085,000 | 9.69% | ||
| 5 | ACORDA THERAPEUTICS INC | 773,090 | 15,230,000 | 7.00% | ||
| 6 | MAGELLAN HEALTH INC COM NEW | 98,700 | 7,195,000 | 3.31% | ||
| 7 | MERIDIAN BIOSCIENCE INC COM | 123,300 | 1,942,000 | 0.89% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-17-005088, filed 2017.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
